首页> Expert opinion on investigational drugs> Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

导出原文传递

翻译打印收藏纠错

第一作者： D'Amico

作者： D'Amico ^[1] ; Fiorino ; G. ; Furfaro ; F. ; Allocca ; M. ; Danese ; S.

作者单位： Department of Biomedical Sciences, Humanitas University, Milan, Italy ^[1]

关键词 future perspectives IBD JAK inhibitors phase I and II clinical trials

发布时间 2020-09-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Expert opinion on investigational drugs

2018年27卷7/12期

595-599页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览3

Expert opinion on investigational drugs

2018年27卷7/12期

595-599页

检索历史清除

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

Expert opinion on investigational drugs

相似文献

同项目论文

Expert opinion on investigational drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

Expert opinion on investigational drugs

相似文献

同项目论文

Expert opinion on investigational drugs

相关期刊

检索历史清除